Osteoarthritis affects millions of people worldwide. Stem cells opened a new perspective in the treatment of this pathology, and today intra articular injection of ADSCs (Adipose-Derived Stem cells) is the most advanced approach to the problem.
What is osteoarthritis?
Osteoarthritis is a disease characterized by the deterioration of cartilage in joints. During movement this slippery tissue (that in joints covers bone extremities) would act as a shock absorber. However, losing cartilage make bones rub together. Over time this situation leads to joint permanent damage and stiffness, causing pain and swelling.
The most affected are hands, knees, hips, and spine joints. They can deteriorate because of aging, injuries or overweight.
There is no cure for osteoarthritis. As the situation worsens, bony spikes or extra bone may form around the joint, and the motion can be severely reduced.
Some drugs (such as nonsteroidal anti-inflammatory drugs) or tips (rest, heat and cold compresses, and, if needed, losing weight) can help relieve pain; however, they do not eliminate its causes. Exercise (in particular swimming) and physical therapy can help maintain movement and balance.
In some cases, surgical treatment is needed to repair or replace damaged joints. Fortunately, today Regenerative Medicine offers a good alternative to joint replacement to manage osteoarticular symptoms: stem cell-based treatments.
Treating osteoarthritis with ADSCs
Adipose-derived stem cells (ADSCs) can be easily obtained from fat collected from the patient that will undergo osteoarthritis treatment, during a rapid and painless outpatient procedure. When injected straight into the joint, ADSCs substitute aged or damaged cells for new, dynamic cells.
The treatment allows tissue self-healing, avoiding the use of medical devices such as prostheses or other artificial components. And the use of patient’s own ADSCs zeroes all risks associated with the introduction of foreign material into the body. In other words, ADSCs injection avoid the risk of contamination, rejection or allergic reaction.
OrthoSkill, the Bioscience ADSCs-based treatment
OrthoSkill is Bioscience Institute ADSCs-based treatment for mild to medium cartilage degeneration. It uses stem cells collected from patient’s fat to trait painful orthopedic condition of knees, hips, shoulders, ankles and other joints. The first results appears evident in 2 to 3 weeks and become complete at the structural level 6 to 8 weeks after the treatment, with fast disappearance of joint pain, and rapid mobility recovery.
Orthopedic surgeons from all over the world agree that the use of ADSCs represents one of the best approaches to treat the degeneration of bone and cartilage tissue. You can discover more about this strategy visiting OrthoSkill webpage or calling the number +971 (0)4 375 7220.